Alpha Tau Medical Ltd. (DRTSW) Capital expenditures 2019–2025
Alpha Tau Medical Ltd. (DRTSW) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$6.1MFY2025 · since FY2019: $1.3M → $6.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $6.1M | +171.4% |
| FY2024 | $2.2M | -65.0% |
| FY2023 | $6.4M | +608.1% |
| FY2022 | $904,000 | -69.1% |
| FY2021 | $2.9M | -22.3% |
| FY2020 | $3.8M | +191.3% |
| FY2019 | $1.3M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice
More DRTSW financial trends
DRTSW RevenueDRTSW Net incomeDRTSW Net marginDRTSW Gross profitDRTSW Gross marginDRTSW Operating incomeDRTSW Operating marginDRTSW Operating cash flowDRTSW Free cash flowDRTSW Return on equityDRTSW Stock buybacksDRTSW Dividends paidDRTSW Total assetsDRTSW Total liabilitiesDRTSW Shareholders’ equityDRTSW overview →